Do you want to read an article? Please log in or register.
Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme
Cardiovascular Risk and DiseasesHypertensionLipid-Lowering Drugs
Related content
RECOMMENDED
Cardiovascular Risk and Diseases
Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)
Eur Heart J Acute Cardiovasc Care.
Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E, Cobain M, Piepoli MF, Visseren FL, Dendale P
doi: 10.1177/2048872619858285.
Heart, Artery and Coronary Diseases
Eligibility and Preventive Potential for New Evidence-Based Cardiovascular Drugs in Secondary Prevention
JAMA Cardiol.
Mortensen MB, Blaha MJ, Nordestgaard BG
doi: 10.1001/jamacardio.2019.4759.
Cardiovascular Risk and Diseases
Plant-Based Diets Are Associated With a Lower Risk of Incident Cardiovascular Disease, Cardiovascular Disease Mortality, and All-Cause Mortality in a General Population of Middle-Aged Adults
J Am Heart Assoc.
Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Coresh J, Rebholz CM
doi: 10.1161/JAHA.119.012865.
Cardiovascular Risk and Diseases
Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association
Circulation
Parikh NI, Gonzalez JM, Anderson CAM, Judd SE, Rexrode KM, Hlatky MA, Gunderson EP, Stuart JJ, Vaidya D, American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council.
doi: 10.1161/CIR.0000000000000961
RECOMMENDED
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
doi: 10.1016/S0140-
RECOMMENDED
Cardiovascular Risk and DiseasesLipid-Lowering Drugs
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Circ Cardiovasc Qual Outcomes
Saeed A, Zhu J, Thoma F, Marroquin O, Aiyer A, Agarwala A, Virani SS, Gulati M, Lee JS, Reis S, Saba S, Ballantyne C, Mulukutla S
doi: 10.1161/CIRCOUTCOMES.120.007485
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management Among Midlife and Older Adults: A Scientific Statement From the American Heart Association
Circulation
Laddu D, Ma J, Kaar J, Ozemek C, Durant RW, Campbell T, Welsh J, Turrise S, American Heart Association Behavioral Change for Improving Health Factors Committee of the Council on Epidemiology and Prevention and the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; and Stroke Council.
doi: 10.1161/CIR.0000000000001026
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
JAMA Intern Med.
Gooding HC, Ning H, Gillman MW, Shay C, Allen N, Goff DC Jr, Lloyd-Jones D, Chiuve S
doi: 10.1001/
Cardiovascular Risk and DiseasesLipid-Lowering Drugs
LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up
Circulation.
Vallejo-Vaz AJ, Robertson M, Catapano AL, Watts GF, Kastelein JJ, Packard CJ, Ford I, Ray KK
doi: 10.1161/